BBS-Bioactive Bone Substitutes Oyj

Share · FI4000260583 (XHEL)

Overview

No Price

n/a

Share Float & Liquidity

Free Float 55,38 %

Shares Float 15,47 M

Shares Outstanding 27,94 M

Company Profile for BBS-Bioactive Bone Substitutes Oyj Share

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.

AI Analysis of BBS-Bioactive Bone Substitutes Oyj

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of BBS-Bioactive Bone Substitutes Oyj

No AI threads available for this company yet.

Company Data

Name BBS-Bioactive Bone Substitutes Oyj

Company BBS-Bioactive Bone Substitutes Oyj

Website https://www.bbs-artebone.fi

Primary Exchange

NASDAQ HELSINKI LTD

ISIN FI4000260583

Asset Class Share

Sector Healthcare

Industry Medical - Devices

CEO Juliusz Rakowskias

Country Finland

Currency EUR

Employees 0,0 T

Address Kiviharjunlenkki 6, 90220 Oulu

IPO Date 2018-02-28

Ticker Symbols

Name	Symbol
NASDAQ HELSINKI LTD	BONEH.HE

More Shares

Investors who hold BBS-Bioactive Bone Substitutes Oyj also have the following shares in their portfolio:

AETERNA ZENTARIS INC Share

DZ BANK IS.A2789 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog